REQUEST A DEMO
Total
USD $0.00
Search more companies

Arex Pharma S.R.O. (Czech Republic)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Arex Pharma S.R.O. Profile Updated: November 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Arex Pharma S.R.O. is an enterprise based in Czech Republic. Its main office is in Prague. The enterprise operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. Arex Pharma S.R.O. was incorporated on March 15, 2013. There are currently 10 - 19 (2024) people employed by Arex Pharma S.R.O.. From the latest financial highlights, Arex Pharma S.R.O. reported a net sales revenue increase of 3.29% in 2022. Over the same period, its total assets grew by 8%. In 2022, Arex Pharma S.R.O.’s net profit margin decreased by 1.09%.

Headquarters
K sokolovne 218
Prague; The City of Prague; Postal Code: 10400

Contact Details: Purchase the Arex Pharma S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Arex Pharma S.R.O. report to view the information.
Outstanding Shares:
Purchase the Arex Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Arex Pharma S.R.O. report to view the information.
Incorporation Date:
March 15, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
67%
Purchase this report to view the information.
33%
Company Performance
Financial values in the chart are available after Arex Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
3.29%
Total operating revenue
3.26%
Operating profit (EBIT)
-30.91%
EBITDA
-29.16%
Net Profit (Loss) for the Period
-44.43%
Total assets
8%
Total equity
14.77%
Operating Profit Margin (ROS)
-1.04%
Net Profit Margin
-1.09%
Return on Equity (ROE)
-26.27%
Quick Ratio
-0.26%
Cash Ratio
0.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?